X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. SHASUN PHARMA FDC LTD./
SHASUN PHARMA
 
P/E (TTM) x 24.4 123.9 19.7% View Chart
P/BV x 4.9 8.5 57.0% View Chart
Dividend Yield % 1.0 0.2 417.4%  

Financials

 FDC LTD.   SHASUN PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
SHASUN PHARMA
Mar-14
FDC LTD./
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs14494 152.3%   
Low Rs7946 173.2%   
Sales per share (Unadj.) Rs47.6214.2 22.2%  
Earnings per share (Unadj.) Rs7.65.3 142.6%  
Cash flow per share (Unadj.) Rs9.015.8 57.0%  
Dividends per share (Unadj.) Rs2.251.00 225.0%  
Dividend yield (eoy) %2.01.4 141.4%  
Book value per share (Unadj.) Rs47.553.3 89.1%  
Shares outstanding (eoy) m177.8356.62 314.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.3 716.7%   
Avg P/E ratio x14.613.1 111.6%  
P/CF ratio (eoy) x12.34.4 279.4%  
Price / Book Value ratio x2.31.3 178.6%  
Dividend payout %29.618.7 157.8%   
Avg Mkt Cap Rs m19,7843,958 499.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2212,164 56.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,45912,127 69.8%  
Other income Rs m394229 171.6%   
Total revenues Rs m8,85212,356 71.6%   
Gross profit Rs m2,0701,009 205.2%  
Depreciation Rs m249594 42.0%   
Interest Rs m31415 7.5%   
Profit before tax Rs m2,184230 950.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250 74,966.7%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606-73 -832.7%   
Profit after tax Rs m1,353302 447.9%  
Gross profit margin %24.58.3 294.1%  
Effective tax rate %27.7-31.7 -87.6%   
Net profit margin %16.02.5 642.1%  
BALANCE SHEET DATA
Current assets Rs m4,3556,884 63.3%   
Current liabilities Rs m1,7928,456 21.2%   
Net working cap to sales %30.3-13.0 -233.8%  
Current ratio x2.40.8 298.5%  
Inventory Days Days4462 72.1%  
Debtors Days Days25108 22.9%  
Net fixed assets Rs m3,0254,970 60.9%   
Share capital Rs m179113 157.6%   
"Free" reserves Rs m8,2432,875 286.7%   
Net worth Rs m8,4533,020 279.9%   
Long term debt Rs m111,817 0.6%   
Total assets Rs m10,55713,347 79.1%  
Interest coverage x71.41.6 4,597.5%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x0.80.9 88.2%   
Return on assets %13.15.4 244.0%  
Return on equity %16.010.0 160.0%  
Return on capital %23.513.3 176.5%  
Exports to sales %13.346.4 28.7%   
Imports to sales %3.314.2 23.5%   
Exports (fob) Rs m1,1265,622 20.0%   
Imports (cif) Rs m2831,728 16.4%   
Fx inflow Rs m1,1465,843 19.6%   
Fx outflow Rs m3552,173 16.3%   
Net fx Rs m7913,669 21.6%   
CASH FLOW
From Operations Rs m1,485398 373.5%  
From Investments Rs m-620-1,635 37.9%  
From Financial Activity Rs m-7531,309 -57.5%  
Net Cashflow Rs m11371 158.4%  

Share Holding

Indian Promoters % 68.9 39.2 175.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 3.6 130.6%  
FIIs % 7.5 17.6 42.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 39.6 48.0%  
Shareholders   23,730 20,750 114.4%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jun 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - SHASUN PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS